Vivo Capital

Latest statistics and disclosures from Vivo Capital's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Vivo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Vivo Capital

Vivo Capital holds 47 positions in its portfolio as reported in the September 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Soleno Therapeutics Common (SLNO) 12.4 $154M -42% 2.3M 67.60
 View chart
Verona Pharma Sponsored Ads (VRNA) 12.0 $149M 1.4M 106.71
 View chart
Cidara Therapeutics Common (CDTX) 10.1 $126M 1.3M 95.76
 View chart
Terns Pharmaceuticals Common (TERN) 4.2 $52M 6.9M 7.51
 View chart
Trevi Therapeutics Common (TRVI) 3.8 $47M +13% 5.1M 9.15
 View chart
Avadel Pharmaceuticals Adr (AVDL) 3.3 $41M 2.7M 15.27
 View chart
Cogent Biosciences Common (COGT) 3.2 $40M +148% 2.8M 14.36
 View chart
Sinovac Biotech SHS 3.1 $38M 5.9M 6.47
 View chart
Oric Pharmaceuticals Common (ORIC) 3.0 $38M 3.1M 12.00
 View chart
Geron Corp Common (GERN) 3.0 $37M 27M 1.37
 View chart
Compass Therapeutics Common (CMPX) 2.7 $33M +57% 9.5M 3.50
 View chart
Dyne Therapeutics Common (DYN) 2.7 $33M +134% 2.6M 12.65
 View chart
Abivax SA - Sponsored Ads (ABVX) 2.5 $31M NEW 359k 84.90
 View chart
Bright Minds Biosciences Common (DRUG) 2.4 $30M +99% 502k 60.66
 View chart
Tourmaline Bio Common (TRML) 2.3 $28M 592k 47.83
 View chart
Zenas Biopharma Common (ZBIO) 2.1 $26M 1.2M 22.20
 View chart
Verastem Common (VSTM) 1.9 $23M +71% 2.6M 8.83
 View chart
SAB Biotherapeutics Common (SABS) 1.8 $23M NEW 11M 2.01
 View chart
Viridian Therapeutics Common (VRDN) 1.7 $21M 983k 21.58
 View chart
Akero Therapeutics Common (AKRO) 1.7 $21M 435k 47.48
 View chart
Erasca Common (ERAS) 1.6 $20M +37% 9.3M 2.18
 View chart
Rezolute Common (RZLT) 1.6 $20M 2.1M 9.40
 View chart
Aclaris Therapeutics Common (ACRS) 1.4 $17M 8.9M 1.90
 View chart
Corvus Pharmaceuticals Holdings Common (CRVS) 1.3 $17M 2.2M 7.37
 View chart
Olema Pharmaceuticals Common (OLMA) 1.2 $15M 1.5M 9.79
 View chart
Dianthus Therapeutics Common (DNTH) 1.1 $14M NEW 354k 39.35
 View chart
LB Pharmaceuticals Common 1.0 $13M NEW 800k 15.79
 View chart
CAMP4 Therapeutics Common (CAMP) 0.9 $12M NEW 3.9M 3.00
 View chart
Astria Therapeutics Common (ATXS) 0.9 $11M 1.6M 7.28
 View chart
Pepgen Common (PEPG) 0.9 $11M NEW 2.3M 4.62
 View chart
DBV Technologies SA Sponsored Ads (DBVT) 0.8 $11M 1.1M 10.00
 View chart
Praxis Precision Medicines Common (PRAX) 0.8 $11M +18% 199k 53.00
 View chart
Abeona Therapeutics Common (ABEO) 0.8 $9.7M 1.8M 5.28
 View chart
Cytomx Therapeutics Common (CTMX) 0.7 $9.2M -50% 2.9M 3.19
 View chart
Eupraxia Pharmaceuticals Common (EPRX) 0.6 $8.0M NEW 1.4M 5.90
 View chart
Unicycive Therapeutics Common (UNCY) 0.6 $7.8M +57% 1.8M 4.36
 View chart
Monopar Therapeutics Common (MNPR) 0.6 $7.4M NEW 91k 81.67
 View chart
Tango Therapeutics Common (TNGX) 0.5 $6.5M +29% 777k 8.40
 View chart
Delcath Systems Common (DCTH) 0.5 $6.1M 570k 10.75
 View chart
Silence Therapeutics Ads (SLN) 0.5 $5.7M 1.1M 5.19
 View chart
89Bio Common (ETNB) 0.4 $5.5M 377k 14.70
 View chart
Instil Bio Common (TIL) 0.4 $5.2M 293k 17.86
 View chart
Sera Prognostics Common (SERA) 0.4 $5.1M 1.7M 3.06
 View chart
Surrozen Common (SRZN) 0.3 $3.4M 260k 12.88
 View chart
Tenax Therapeutics Common (TENX) 0.1 $1.6M 208k 7.61
 View chart
Bolt Therapeutics Common (BOLT) 0.1 $937k 176k 5.32
 View chart
Precision Biosciences Common (DTIL) 0.0 $26k 4.7k 5.52
 View chart

Past Filings by Vivo Capital

SEC 13F filings are viewable for Vivo Capital going back to 2016

View all past filings